This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
Sandbox Reserved 1369
From Proteopedia
(Difference between revisions)
| Line 1: | Line 1: | ||
{{Sandbox_Reserved_HLSC322}}<!-- PLEASE ADD YOUR CONTENT BELOW HERE --> | {{Sandbox_Reserved_HLSC322}}<!-- PLEASE ADD YOUR CONTENT BELOW HERE --> | ||
==Your Heading Here (maybe something like 'Structure')== | ==Your Heading Here (maybe something like 'Structure')== | ||
| - | <StructureSection load=' | + | <StructureSection load='4ZJV' size='340' side='right' caption='Caption for this structure' scene=''> |
This is a protein complex formed from Mitogen-Inducible Gene 6 Protein (Mig-6) and Epidermal Growth Factor Receptor (EGFR)4. Mig-6 complexes with and inhibits EGFR. Mig-6 contains a protein domain that can interact with the EGFR protein family4. EGFR catalyzes the phosphorylation of Mig-6 when the two proteins form a complex, and when this occurs, Mig-6 changes its structure and irreversibly inhibits the EGFR4. | This is a protein complex formed from Mitogen-Inducible Gene 6 Protein (Mig-6) and Epidermal Growth Factor Receptor (EGFR)4. Mig-6 complexes with and inhibits EGFR. Mig-6 contains a protein domain that can interact with the EGFR protein family4. EGFR catalyzes the phosphorylation of Mig-6 when the two proteins form a complex, and when this occurs, Mig-6 changes its structure and irreversibly inhibits the EGFR4. | ||
| + | |||
| + | |||
== Function == | == Function == | ||
EGFR plays a role in the metastasization and development of carcinomas, because it contributes to growth in epithelial tissue.The irreversible inhibition EGFR by Mig-6 will, in people with cancer, prevent the cancer from growing and progressing further. Therefore, Mig-6 regulates the activities of EGFR, so that growth does not get out of control. | EGFR plays a role in the metastasization and development of carcinomas, because it contributes to growth in epithelial tissue.The irreversible inhibition EGFR by Mig-6 will, in people with cancer, prevent the cancer from growing and progressing further. Therefore, Mig-6 regulates the activities of EGFR, so that growth does not get out of control. | ||
== Disease == | == Disease == | ||
| - | The Mig-6/EGFR protein complex has great importance to the prevention and suppression of epithelial tumors. Since EGFR promotes epithelial growth, and therefore the growth of epithelial cancers when they occur, the Mig-6/EGFR complex is essentially a tumor suppressing complex, because Mig-6 inhibits the function of EGFR | + | The Mig-6/EGFR protein complex has great importance to the prevention and suppression of epithelial tumors. Since EGFR promotes epithelial growth, and therefore the growth of epithelial cancers when they occur, the Mig-6/EGFR complex is essentially a tumor suppressing complex, because Mig-6 inhibits the function of EGFR |
== Relevance == | == Relevance == | ||
| - | Mig-6 is a feedback inhibitor that binds, inhibits, and drives internalization of ErbB-family receptors. Mig-6 inactivates the EGFR and thus is critical in better understanding human | + | Mig-6 is a feedback inhibitor that binds, inhibits, and drives internalization of ErbB-family receptors. Mig-6 inactivates the EGFR and thus is critical in better understanding human cancers2. EGFR phosphorylates Mig6 on Y394 and that this phosphorylation is primed by prior phosphorylation of an adjacent residue, Y395, by Src. |
Somatic mutations in the EGFR kinase domain have been shown to drive lung adenocarcinoma, a specific type of lung cancer. Mig-6 is a target for phosphorylation by mutant EGFR’s and is a promising tumor suppressor for mutant-driven lung adenocarcinoma. During a research study, lung tumor formation progressed faster in mice lacking Mig-62. Interaction between Mig-6 and EGFR, stabilizes EGFR, inhibiting mutant EGFR, and preventing or delaying further growth of mutant EGFR-driven tumors. | Somatic mutations in the EGFR kinase domain have been shown to drive lung adenocarcinoma, a specific type of lung cancer. Mig-6 is a target for phosphorylation by mutant EGFR’s and is a promising tumor suppressor for mutant-driven lung adenocarcinoma. During a research study, lung tumor formation progressed faster in mice lacking Mig-62. Interaction between Mig-6 and EGFR, stabilizes EGFR, inhibiting mutant EGFR, and preventing or delaying further growth of mutant EGFR-driven tumors. | ||
| Line 20: | Line 22: | ||
Global Stoichiometry: Hetero 2-mer - AB2 | Global Stoichiometry: Hetero 2-mer - AB2 | ||
| - | The domain structure of Mig6 includes an N-terminal CRIB domain, a motif that mediates association with the Rho-family GTPase Cdc42 and a C-terminal ErbB-binding region, which is necessary and sufficient for binding and inhibition of EGFR7. | + | The domain structure of Mig6 includes an N-terminal CRIB domain, a motif that mediates association with the Rho-family GTPase Cdc42 and a C-terminal ErbB-binding region, which is necessary and sufficient for binding and inhibition of EGFR7. In the Mig6-YpY structure, the kinase adopts an active conformation, and the Mig6 peptide interacts with the activation loop in an antiparallel manner. |
| - | + | ||
</StructureSection> | </StructureSection> | ||
== References == | == References == | ||
| - | + | <2. http://www.rcsb.org/structure/4ZJV | |
| - | + | 3. https://www.ncbi.nlm.nih.gov/pubmed/25735773 | |
| - | 2. | + | 4. https://www.ncbi.nlm.nih.gov/pubmed/16377102 |
| - | + | 5. https://www.ebi.ac.uk/pdbe/entry/pdb/4zjv/citations> | |
| - | 3. | + | |
| - | + | ||
| - | 4. | + | |
| - | + | ||
| - | 5. | + | |
Revision as of 21:54, 21 February 2018
| This Sandbox is Reserved from January through July 31, 2018 for use in the course HLSC322: Principles of Genetics and Genomics taught by Genevieve Houston-Ludlam at the University of Maryland, College Park, USA. This reservation includes Sandbox Reserved 1311 through Sandbox Reserved 1430. |
To get started:
More help: Help:Editing |
Your Heading Here (maybe something like 'Structure')
| |||||||||||
References
<2. http://www.rcsb.org/structure/4ZJV 3. https://www.ncbi.nlm.nih.gov/pubmed/25735773 4. https://www.ncbi.nlm.nih.gov/pubmed/16377102 5. https://www.ebi.ac.uk/pdbe/entry/pdb/4zjv/citations>
